XML 23 R6.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
EOGA
SiteLark
IAL
Common Stock
Common Stock
EOGA
Common Stock
SiteLark
Common Stock
IAL
Treasury Stock
Additional Paid-in Capital
Additional Paid-in Capital
EOGA
Additional Paid-in Capital
SiteLark
Additional Paid-in Capital
IAL
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Non-controlling Interests
Beginning balance at Dec. 31, 2013 $ 249,752       $ 6       $ (15,176) $ 266,122       $ (359) $ (841)  
Beginning balance (in shares) at Dec. 31, 2013         58,266,000       5,394,000              
Increase (Decrease) in Stockholders' Equity                                
Net (loss) income 53,603                           53,603  
Foreign currency translation adjustment (143)                         (143)    
Stock issued under employee stock purchase plan 906                 906            
Stock issued under employee stock purchase plan (in shares)                 (43,000)              
Common stock issued in payment of accrued liability 600                 600            
Common stock issued in payment of accrued liability (in shares)         27,000                      
Stock warrants exercised $ 1,545                 1,545            
Stock warrants exercised (in shares) 1,277,250       1,277,000                      
Stock options exercised $ 1,660                 1,660            
Stock options exercised (in shares)         312,000                      
Restricted stock granted (in shares)         526,000                      
Restricted stock forfeited (in shares)                 61,000              
Treasury stock purchased $ (6,294)               $ (6,294)              
Treasury stock purchased (in shares) 243,005               243,000              
Stock surrendered for exercise of stock options $ (1,198)               $ (1,198)              
Stock surrendered for exercise of stock options (in shares) 46,208               46,000              
Excess tax benefit related to share-based awards $ 3,448                 3,448            
Stock compensation expense 10,476                 10,476            
Investment in Flotek Gulf, LLC and Flotek Gulf Research, LLC 351                             $ 351
Stock issued in acquisition   $ 1,894 $ 149               $ 1,894 $ 149        
Stock issued in acquisition (in shares)           94,000 5,000                  
Repurchase of common stock (10,395)               $ (10,395)              
Repurchase of common stock (in shares)                 621,000              
Retirement of treasury stock 0       $ (1)       $ 32,568 (32,567)            
Retirement of treasury stock (in shares)         (5,873,000)       (5,873,000)              
Ending balance at Dec. 31, 2014 306,354       $ 5       $ (495) 254,233       (502) 52,762 351
Ending balance (in shares) at Dec. 31, 2014         54,634,000       449,000              
Increase (Decrease) in Stockholders' Equity                                
Net (loss) income (13,462)                           (13,462)  
Foreign currency translation adjustment (735)                         (735)    
Stock issued under employee stock purchase plan 879                 879            
Stock issued under employee stock purchase plan (in shares)                 (77,000)              
Common stock issued in payment of accrued liability $ 0                              
Common stock issued in payment of accrued liability (in shares) 0                              
Stock options exercised $ 1,372       $ 1         1,371            
Stock options exercised (in shares) 767,560       768,000                      
Restricted stock granted (in shares) 758,904       758,000                      
Restricted stock forfeited (in shares)                 33,000              
Treasury stock purchased $ (6,345)               $ (6,345)              
Treasury stock purchased (in shares) 473,304               473,000              
Stock surrendered for exercise of stock options $ (1,332)               $ (1,332)              
Stock surrendered for exercise of stock options (in shares) 106,810               107,000              
Excess tax benefit related to share-based awards $ 1,273                 1,273            
Stock compensation expense 14,681                 14,681            
Investment in Flotek Gulf, LLC and Flotek Gulf Research, LLC $ 7                             7
Stock issued in acquisition       $ 1,014                 $ 1,014      
Stock issued in acquisition (in shares) 60,024             60,000                
Repurchase of common stock $ (9,697)               $ (9,697)              
Repurchase of common stock (in shares)                 800,000              
Sale of common stock, net of issuance cost (in shares) 0                              
Ending balance at Dec. 31, 2015 $ 294,009       $ 6       $ (17,869) 273,451       (1,237) 39,300 358
Ending balance (in shares) at Dec. 31, 2015         56,220,000       1,785,000              
Increase (Decrease) in Stockholders' Equity                                
Net (loss) income (49,130)                           (49,130)  
Foreign currency translation adjustment 281                         281    
Stock issued under employee stock purchase plan 833                 833            
Stock issued under employee stock purchase plan (in shares)                 (93,000)              
Common stock issued in payment of accrued liability $ 0                              
Common stock issued in payment of accrued liability (in shares) 20,000                              
Stock options exercised $ 184                 184            
Stock options exercised (in shares) 114,112       114,000                      
Restricted stock granted (in shares) 632,240       653,000                      
Restricted stock forfeited (in shares)                 96,000              
Treasury stock purchased $ (2,350)               $ (2,350)              
Treasury stock purchased (in shares) 238,216               238,000              
Stock surrendered for exercise of stock options $ (50)               $ (50)              
Stock surrendered for exercise of stock options (in shares) 3,225               3,000              
Stock compensation expense $ 13,076                 13,076            
Stock issued in acquisition       $ 3,268                 $ 3,268      
Stock issued in acquisition (in shares) 247,764             248,000                
Sale of common stock, net of issuance cost $ 30,090                 30,090            
Sale of common stock, net of issuance cost (in shares) 2,450,339       2,450,000                      
Reduction in tax benefit related to share-based awards $ (2,510)                 (2,510)            
Ending balance at Dec. 31, 2016 $ 287,701       $ 6       $ (20,269) $ 318,392       $ (956) $ (9,830) $ 358
Ending balance (in shares) at Dec. 31, 2016         59,685,000       2,029,000